Page 1

MLPCARE High Growth Supported by the Base Effect of Pandemic August 12 , 2021 MLP Sağlık Hizmetleri A.Ş. ( “ MLP Care " ) MLP Sağlık Hizmetleri A.Ş. ( BIST : MPARK ) , the leading private healthcare service provider in Turkey , today announces its financial results for the second quarter and the first half of 2021 . ( All figures in this fact sheet include the impact of IFRS 16 unless otherwise stated . ) Summary Financials ( TL million ) Revenue H1 2021 2,542 H1 2020 1,738 Change 46.3 % Q2 2021 1,331 Q2 2020 759 Change 75.3 % EBITDA¹ 676 454 48.8 % 330 EBITDA margin ( % ) 26.6 % 26.1 % 45bps % 24,8 219 % 28,8 50.6 % ( 407bps ) EBITDA¹ ( w / o fx impact ) ² 633 414 52.7 % 320 196 EBITDA margin ( % ) 24.9 % 23.8 % 105bps 24.0 % 25.9 % 62.8 % ( 184bps ) Net Profit / ( Loss ) Before Tax 188 64 192.6 % 73 ( 22 ) n.m. Net Profit / ( Loss ) 174 39 344.5 % 95 ( 22 ) n.m. Net Profit / ( Loss ) ( allocated to equity holders of the parent ) 147 27 435.8 % 82 ( 23 ) n.m. Free Cash Flow 516 302 71.1 % 237 132 79.2 % Capital Expenditure 169 57 197.5 % 126 21 504.0 % Net Debt ( w / o TFRS 16 impact ) 1,390 1,525 ( 8.8 % ) 1,390 1,525 ( 8.8 % ) 1 Adj . EBITDA is based on reported EBITDA ( Earnings Before Interest , Taxes , Depreciation , and Amortization ) adjusted for one- time ( income ) / expenses , net and non - cash GAAP provision expenses 2 Without fx impact of other income / expenses from operating activities 3 Excluding obligations under operational leases related to TFRS 16 Financial Highlights ✓ ✓ In Q2 2021 , total revenue increased by 75 % to TL 1,331 million ( Q2 2020 : TL 759 million ) . The low base effect caused by the 15 % revenue contraction due to pandemic in Q2 2020 , the continued strong growth in domestic patient revenue quarter - on - quarter , and the accelerated recovery of foreign medical tourism revenue were the main drivers . Therefore , in H1 2021 revenue increased by 46 % to TL 2,542 million ( H1 2020 : TL 1,738 million ) . In Q2 2021 , the adj . EBITDA ( w / o fx impact ) increased by 63 % to TL 320 million , while adj . EBITDA ( w / o fx impact ) margin came in at 24.0 % . In H1 2021 , the adj . EBITDA ( w / o fx impact ) increased by 53 % to TL 633 million , while the adj . EBITDA margin increased by 105 bps to 24.9 % . A net profit of TL 95 million was generated in Q2 2021 ( Q2 2020 : TL 22 million loss ) . Net profit allocated to equity holders of the parent was TL 82 million ( share in total : 86 % ) in Q2 2021 ( Q2 2020 : TL 23 million loss ) . Accordingly , net profit in H1 2021 increased to TL 174 million ( H1 2020 : TL 39 million ) . Net profit allocated to equity holders of the parent increased to TL 147 million in H1 2021 ( H1 2020 : TL 27 million ) . Rapid recovery of revenue compared to previous year , effective cost management , and reduction of financial expenses ( mitigating currency risk by closing fx net debt ) have supported the net profit increase . MEDICALPARK livHOS HOSPITAL -1-